Erratum

This article refers to:

Mirabegron in the treatment of overactive bladder

Correction to: Mirabegron in the treatment of overactive bladder

Leone Roberti Maggiore U, Cardozo L, Ferrero S, et al. Mirabegron in the treatment of overactive bladder. Expert Opin. Pharmacother. (2014);15(6):873-87

Following publication of this article, errors were identified in the author list. The author Fabio Del Deo (Fabio is the given name and Del Deo is the surname) was missed in the final version of the paper.

The full author list should have read:

Umberto Leone Roberti Maggiore¹ MD, Linda Cardozo² MD, Simone Ferrero^†3 PhD, Filomena Sileo¹ MD, Alice Cola¹, Fabio Del Deo⁴, Marco Torella⁴ MD, Nicola Colacurci⁴ MD, Massimo Candiani¹ MD & Stefano Salvatore¹ MD

^†Author for correspondence

¹IRRCS San Raffaele Hospital and Vita-Salute San Raffaele University, Via Olgettina 58-60, 20132, Milan, Italy

²King’s College Hospital, Department of Urogynaecology, Denmark Hill, London, SE5 9RS, UK

³University of Genoa, San Martino Hospital and National Institute for Cancer Research, Department of Obstetrics and Gynecology, Largo R. Benzi 1, 16132, Genoa, Italy

 Tel: [phone];

 Fax: [phone];

 E-mail: [email protected]

⁴Child and of General and Specialized Surgery Second University of Studies of Naples, Department of Woman, 80138 Naples, Italy